ConductScience.org, home

Paper22101652

Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.

Cirri P and 1 other. Cancer Metastasis Rev, 2012. Cited by 420 papers, by iCite.

Cite this record

ConductScience Library. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Papers, record 22101652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22101652

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.
PubMed
Journal
Cancer Metastasis Rev
PubMed
Year
2012
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
420
iCite
Relative citation ratio, by iCite
11.2
iCite
Revised in PubMed
2022-03-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cirri PPaolo
2Chiarugi PPaola

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FibroblastsMajor topic
NeoplasmsMajor topic
Disease Progression
Epithelial-Mesenchymal Transition
Humans
Stromal Cells
Tumor Microenvironment

Source PubMed

Download CSV of topics

Cited by280

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 420 citations.

PMIDTitleJournalYearIn PapersSource
42554469Hippo Pathway Regulation and Microenvironmental Cues Governing Human MSC Transition to Cancer-Associated Fibroblasts.J Cell Physiol2026https://conductscience.org/library/papers/42554469PubMed
42517964Cancer-associated fibroblasts: The silent conductors of tumor evolution and therapy refractoriness.Mol Biol Rep2026https://conductscience.org/library/papers/42517964PubMed
42353345From Chronic Inflammation to Malignancy: Molecular Mechanisms and Therapeutic Insights in Oral Carcinogenesis.Int J Mol Sci2026https://conductscience.org/library/papers/42353345PubMed
42088621BDKRB1 Links Copy Number-Defined Genomic Instability to Inflammatory and Immunosuppressive Tumor Ecosystems in Ovarian Cancer: An Integrative Multiomics Analysis.Int J Genomics2026https://conductscience.org/library/papers/42088621PubMed
41799193Identification of programmed cell death-related subtypes reveals immune heterogeneity and therapeutic divergence in colon cancer.Theranostics2026https://conductscience.org/library/papers/41799193PubMed
41423542Cancer-associated fibroblasts at the crossroads of tumor progression and therapy resistance: from heterogeneity to precision reprogramming.J Egypt Natl Canc Inst2025https://conductscience.org/library/papers/41423542PubMed
41293172A mitochondrial lipid metabolism-related gene signature predicts prognosis and immune landscape in colorectal cancer.Front Immunol2025https://conductscience.org/library/papers/41293172PubMed
41284138Colorectal cancer cell-derived exosomes induce metabolic reprogramming of cancer-associated fibroblasts to promote colorectal cancer growth.Discov Oncol2025https://conductscience.org/library/papers/41284138PubMed
41033664Revolutionizing Solid Tumor Surgery with Fibroblast Activation Protein (FAP)-Targeted Imaging Probes for a Fluorescence-Guided Surgery of Pancreatic Cancer.Bioconjug Chem2025https://conductscience.org/library/papers/41033664PubMed
40973793Cancer-associated fibroblasts drive lung adenocarcinoma progression via THBS2-mediated epithelial-mesenchymal transition.Oncogene2025https://conductscience.org/library/papers/40973793PubMed
40959429A mitochondrial ferroptosis-related gene signature predicts prognosis and immune landscape in colon cancer.Front Med (Lausanne)2025https://conductscience.org/library/papers/40959429PubMed
40665579Cancer stem cells: Bridging microenvironmental interactions and clinical therapy.Clin Transl Med2025https://conductscience.org/library/papers/40665579PubMed
40591015FAP as a prognostic biomarker and radiomics-based predictor of angiogenesis-associated recurrence in Adamantinomatous craniopharyngioma.Pituitary2025https://conductscience.org/library/papers/40591015PubMed
40558563Free Methylglyoxal and Lactate Produced and Released by Cultured Cancer and Non-Cancer Cells: Implications for Tumor Growth and Development.Cells2025https://conductscience.org/library/papers/40558563PubMed
40299639A Nexus of Biomolecular Complexities in Pituitary Neuroendocrine Tumors: Insights into Key Molecular Drivers.Biomedicines2025https://conductscience.org/library/papers/40299639PubMed
40094065Advances in nanotechnology for targeting cancer-associated fibroblasts: A review of multi-strategy drug delivery and preclinical insights.APL Bioeng2025https://conductscience.org/library/papers/40094065PubMed
39816375Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy.Int J Nanomedicine2025https://conductscience.org/library/papers/39816375PubMed
39588377Current hotspots and trends in cancer metabolic reprogramming: a scientometric analysis.Front Immunol2024https://conductscience.org/library/papers/39588377PubMed
39482912Molecular Targets and Nano-Technological Approaches in the Treatment of Hepatic Carcinoma.Curr Cancer Drug Targets2025https://conductscience.org/library/papers/39482912PubMed
39440039Different subpopulations of macrophages, neutrophils, mast cells, and fibroblasts are involved in the control of tumor angiogenesis.Front Med (Lausanne)2024https://conductscience.org/library/papers/39440039PubMed

See all 280 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22101652

GET https://conductscience.org/api/papers/v1/22101652/cited_by?page=2